Clinical Trial Update: Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating parasite clearance time and time to recurrent infection after treatment with Artemether/Lumefantrine for malaria. The f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artemether/Lumefantrine (Coartem) (Artemether; Lumefantrine)

Snippet

Sponsor: Muhimbili University of Health and Allied Sciences | Conditions: Instantaneous Clearance | Phase 4 | Status: COMPLETED